Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, September 1, 2023

Management of stroke in the new era of oral anticoagulation - WSO Academy

You can see how useless the WSO is; 'Management' NOT RECOVERY OR RESULTS! Survivors would like to fully recover. Don't you ever talk to survivors and ask what they want

Management of stroke in the new era of oral anticoagulation

Learning Objectives:

  • Comprehensive Understanding of Stroke Prevention in Atrial Fibrillation
  • Navigating Antithrombotic Therapies for Stroke Prevention
  • Translating Research into Practice for Enhanced Stroke Care

Scientific Program:

  • Chair Introductions: Valeria Caso, Italy
  • Burden of atrial fibrillation (AF) in stroke care: Cecilia Bahit, Argentin
  • Antithrombotic Guidelines and unmet needs: Jan Scheitz, Germany
  • Completed Phase II, and ongoing Phase III, Factor XI(a) inhibitor trials in AF or non-cardioembolic ischemic stroke: Ashkan Shoamanesh, Canada
  • Q&A Discussion

Date and Time: September 19th, 3pm (CEST)

This webinar is supported by an unrestricted educational grant by Bayer AG.

Speakers:

  • Dr. Cecilia Bahit, Chief of Cardiology, INECO Neurociencias Rosario, Argentina and Co-Chair Heart & Brain Task Force, World Stroke Organization
  • Dr. Jan Scheitz, Professor of Clinical Stroke Research at Center for Stroke Research Berlin and Consultant Stroke Neurologist at Charité University Hospital
  • Dr. Ashkan Shoamanesh, Associate Professor of Medicine (Neurology) at McMaster University, Hamilton, Canada

Moderator:

  • Dr. Valeria Caso, Consultant Neurologist at the Stroke Unit, Santa Maria della Misericordia Hospital, University of Perugia, Italy

 

Posted by at
Labels: , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)